These can be GLP-1 therapies, non-GLP-1 therapies, or both
(A 2022 clinical trial published in the New England Journal of Medicine found that roughly 80% of people taking Zepbound did.) Research and obesity medicine specialists have identified a few common patterns for when symptoms tend to flare up: Early on, especially during the first few weeks Within 48 hours of an injection After a dose increase Individual bouts of nausea, diarrhea and vomiting often pass within a few days, though constipation can stick around much longer
However, these drugs require subcutaneous administration, which may limit their early use
At Lite Medical, we approach obesity as a metabolic condition, not a character flaw
GLP1files does not provide medical advice, prescriptions, or treatment decisions
How long do I need to take either medication